NEW YORK, Jan. 17, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of HTG Molecular Diagnostics, Inc. HTGM, Momenta Pharmaceuticals, Inc. MNTA, Black Knight Financial Services, Inc. BKI, Verint Systems Inc. VRNT, IBERIABANK Corporation IBKC, and Sterling Construction Company Inc STRL, including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
HTGM DOWNLOAD: http://Fundamental-Markets.com/register/?so=HTGM
MNTA DOWNLOAD: http://Fundamental-Markets.com/register/?so=MNTA
BKI DOWNLOAD: http://Fundamental-Markets.com/register/?so=BKI
VRNT DOWNLOAD: http://Fundamental-Markets.com/register/?so=VRNT
IBKC DOWNLOAD: http://Fundamental-Markets.com/register/?so=IBKC
STRL DOWNLOAD: http://Fundamental-Markets.com/register/?so=STRL
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine HTG Molecular Diagnostics, Inc. HTGM, Momenta Pharmaceuticals, Inc. MNTA, Black Knight Financial Services, Inc. BKI, Verint Systems Inc. VRNT, IBERIABANK Corporation IBKC, and Sterling Construction Company Inc STRL on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed January 15th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
HTG MOLECULAR DIAGNOSTICS, INC. (HTGM) REPORT OVERVIEW
HTG Molecular Diagnostics' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, HTG Molecular Diagnostics reported revenue of $3.72MM vs $0.91MM (up 307.43%) and basic earnings per share -$0.46 vs -$0.92. For the twelve months ended December 31st, 2016 vs December 31st, 2015, HTG Molecular Diagnostics reported revenue of $5.13MM vs $4.04MM (up 27.00%) and basic earnings per share -$3.66 vs -$5.03. HTG Molecular Diagnostics is expected to report earnings on March 22nd, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.76. The estimated EPS forecast for the next fiscal year is -$1.00 and is expected to report on March 22nd, 2018.
To read the full HTG Molecular Diagnostics, Inc. (HTGM) report, download it here: http://Fundamental-Markets.com/register/?so=HTGM
-----------------------------------------
MOMENTA PHARMACEUTICALS, INC. (MNTA) REPORT OVERVIEW
Momenta Pharmaceuticals' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Momenta Pharmaceuticals reported revenue of $24.09MM vs $29.14MM (down 17.34%) and basic earnings per share -$0.44 vs -$0.26. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Momenta Pharmaceuticals reported revenue of $109.62MM vs $89.65MM (up 22.27%) and basic earnings per share -$0.31 vs -$1.32. Momenta Pharmaceuticals is expected to report earnings on February 20th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for the next fiscal year is -$1.25 and is expected to report on February 20th, 2018.
To read the full Momenta Pharmaceuticals, Inc. (MNTA) report, download it here: http://Fundamental-Markets.com/register/?so=MNTA
-----------------------------------------
BLACK KNIGHT FINANCIAL SERVICES, INC. (BKI) REPORT OVERVIEW
Black Knight Financial Services' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Black Knight Financial Services reported revenue of $263.80MM vs $267.10MM (down 1.24%) and basic earnings per share $0.22 vs $0.17 (up 29.41%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Black Knight Financial Services reported revenue of $1,026.00MM vs $930.70MM (up 10.24%) and basic earnings per share $0.69 vs $0.31 (up 122.58%). Black Knight Financial Services is expected to report earnings on February 7th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.27. The estimated EPS forecast for the next fiscal year is $1.65 and is expected to report on February 7th, 2018.
To read the full Black Knight Financial Services, Inc. (BKI) report, download it here: http://Fundamental-Markets.com/register/?so=BKI
-----------------------------------------
VERINT SYSTEMS INC. (VRNT) REPORT OVERVIEW
Verint's Recent Financial Performance
For the three months ended October 31st, 2017 vs October 31st, 2016, Verint reported revenue of $280.73MM vs $258.90MM (up 8.43%) and basic earnings per share $0.04 vs -$0.13. For the twelve months ended January 31st, 2017 vs January 31st, 2016, Verint reported revenue of $1,062.11MM vs $1,130.27MM (down 6.03%) and basic earnings per share -$0.47 vs $0.29. Verint is expected to report earnings on March 27th, 2018. The report will be for the fiscal period ending January 31st, 2018. The reported EPS for the same quarter last year was $0.64. The estimated EPS forecast for the next fiscal year is $2.16 and is expected to report on March 27th, 2018.
To read the full Verint Systems Inc. (VRNT) report, download it here: http://Fundamental-Markets.com/register/?so=VRNT
-----------------------------------------
IBERIABANK CORPORATION (IBKC) REPORT OVERVIEW
IBERIABANK's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, IBERIABANK reported interest income of $246.97MM vs $180.50MM (up 36.82%) and basic earnings per share $0.49 vs $1.08 (down 54.63%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, IBERIABANK reported interest income of $716.94MM vs $646.86MM (up 10.83%) and basic earnings per share $4.32 vs $3.69 (up 17.07%). IBERIABANK is expected to report earnings on January 25th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $1.16. The estimated EPS forecast for the next fiscal year is $6.12 and is expected to report on January 25th, 2018.
To read the full IBERIABANK Corporation (IBKC) report, download it here: http://Fundamental-Markets.com/register/?so=IBKC
-----------------------------------------
STERLING CONSTRUCTION COMPANY INC (STRL) REPORT OVERVIEW
Sterling Construction's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Sterling Construction reported revenue of $304.22MM vs $205.63MM (up 47.95%) and basic earnings per share $0.27 vs $0.10 (up 170.00%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Sterling Construction reported revenue of $690.12MM vs $623.60MM (up 10.67%) and basic earnings per share -$0.40 vs -$2.02. Sterling Construction is expected to report earnings on March 8th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.25. The estimated EPS forecast for the next fiscal year is $0.98 and is expected to report on March 8th, 2018.
To read the full Sterling Construction Company Inc (STRL) report, download it here: http://Fundamental-Markets.com/register/?so=STRL
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
